HC
GILD icon

Hamilton Capital’s Gilead Sciences GILD Stock Holding History

Hamilton Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$546K Sell
3,916
-1,228
-24% -$172K 0.03% 70
2025
Q4 		$631K Buy
+5,144
New +$625K 0.03% 58
2025
Q2 		$509K Buy
4,594
+264
+6% +$28.1K 0.03% 64
2025
Q1 		$485K Sell
4,330
-54
-1% -$5.57K 0.03% 64
2024
Q4 		$405K Buy
4,384
+160
+4% +$14.4K 0.03% 67
2024
Q3 		$375K Buy
4,224
+229
+6% +$17.5K 0.03% 75
2024
Q2 		$274K Sell
3,995
-2,917
-42% -$195K 0.02% 89
2024
Q1 		$506K Buy
6,912
+807
+13% +$62.1K 0.04% 60
2023
Q4 		$495K Buy
6,105
+2,477
+68% +$193K 0.04% 60
2023
Q3 		$272K Sell
3,628
-372
-9% -$28.6K 0.02% 88
2023
Q2 		$308K Buy
4,000
+524
+15% +$41.8K 0.02% 78
2023
Q1 		$288K Buy
3,476
+501
+17% +$41.5K 0.02% 85
2022
Q4 		$255K Buy
+2,975
New +$236K 0.02% 110

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Hamilton Capital's GILD Position: Q1 2026 in Review

Hamilton Capital reduced its Gilead Sciences (GILD) stake by 24% in Q1 2026, selling an estimated $172K and leaving 3,916 shares worth $546K. The position accounts for 0.03% of the portfolio, ranked #70.

Hamilton Capital first reported a position in GILD in Q4 2022 and has held it in 13 quarters since. The position peaked at $631K in Q4 2025. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Hamilton Capital held 3,916 shares of Gilead Sciences worth $546K as of Q1 2026.
  • Hamilton Capital sold 1,228 Gilead Sciences shares in Q1 2026, an estimated $172K.
  • Gilead Sciences made up 0.03% of Hamilton Capital's portfolio in Q1 2026, its #70 holding.
  • Hamilton Capital first reported a position in Gilead Sciences in Q4 2022 and has held it in 13 quarters since.
  • Hamilton Capital's Gilead Sciences position peaked at $631K in Q4 2025.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Hamilton Capital's 13F filing for Q1 2026, filed 15 May 2026.